Language: BG BG
← Back to results
Recruiting Phase 1 NCT04861051

Understanding Ketamine's Dissociative Effects (KD Study)

Phase 1 – testing safety in a small group of people
Conditions: Epilepsy

Sponsor: Stanford University

trial.available_in: БГ
Overview
The purpose of this study is to understand how ketamine brings about dissociative symptoms.
Description
The goal of this proposed research is to record the effects of ketamine on brain activity to understand the changes that occur during dissociation in epilepsy patients with stereoEEG.
Who can participate
Inclusion Criteria: * Patient in Stanford Epilepsy Monitoring Unit * Age \>18 years old. Exclusion Criteria: * Lifetime psychotic or bipolar disorder * Inability to speak, read or understand English * Pregnant or nursing females * Prior adverse ketamine response
Interventions
Ketamine
DRUG
Locations 1
United States (1)
Stanford University School of Medicine
Palo Alto , California
Technical details
Status
Recruiting
Phase
Phase 1
Study type
INTERVENTIONAL
Sex
Male and female
Minimum age
18 Years
Healthy volunteers
No
Start date
26.07.2021
Completion date
01.08.2028
Registry ID
NCT04861051
Source
clinicaltrials.gov
trial.inquiry_btn

Information is automatically extracted from ClinicalTrials.gov. Consult your doctor before taking action.